Deferred Income Tax Liabilities, Net in USD of NKGen Biotech, Inc. from Q4 2022 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
NKGen Biotech, Inc. quarterly Deferred Income Tax Liabilities, Net history and change rate from Q4 2022 to Q4 2024.
  • NKGen Biotech, Inc. Deferred Income Tax Liabilities, Net for the quarter ending 31 Dec 2024 was $8K, a 75.8% decline year-over-year.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Change (%)

NKGen Biotech, Inc. Quarterly Deferred Income Tax Liabilities, Net (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $8K -$25K -75.8% 31 Dec 2024 10-K 08 Oct 2025
Q3 2024 $33K +$7K +26.9% 30 Sep 2024 10-Q 04 Mar 2025
Q2 2024 $33K 30 Jun 2024 10-Q 12 Sep 2024
Q1 2024 $33K 31 Mar 2024 10-Q 20 May 2024
Q4 2023 $33K +$7K +26.9% 31 Dec 2023 10-K 08 Oct 2025
Q3 2023 $26K 30 Sep 2023 10-Q 14 Nov 2023
Q4 2022 $26K 31 Dec 2022 10-K 16 Apr 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.